| Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
| GABRA6 |
gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
5q34 |
1(0/1/0)
|
TAS[8632757]
|
| GABRB1 |
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
4p12 |
3(2/0/1)
|
TAS[2465923]
|
| PDE10A |
phosphodiesterase 10A |
6q26 |
1(0/1/0)
|
IEA
|
| AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
14q32.33 |
3(3/0/0)
|
TAS[21432781]
|
| RGS5 |
regulator of G-protein signaling 5 |
1q23.1 |
1(0/0/1)
|
IEA
|
| CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
11q23 |
1(0/0/1)
|
TAS[1373520]
|
| GABRB3 |
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
15q12 |
3(1/2/0)
|
TAS[1664410]
|
| NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
5q31-q32 |
5(2/3/0)
|
TAS[7769088]
|
| NR3C2 |
nuclear receptor subfamily 3, group C, member 2 |
4q31 |
1(1/0/0)
|
TAS[3037703]
|
| PPP3CB |
protein phosphatase 3, catalytic subunit, beta isozyme |
10q22.2 |
2(1/1/0)
|
NAS[8978785]
|
| TENM4 |
teneurin transmembrane protein 4 |
11q13 |
6(4/2/0)
|
IEA
|
| PI4KA |
phosphatidylinositol 4-kinase, catalytic, alpha |
22q11.21 |
3(1/2/0)
|
NAS[7961848]
|
| ELK3 |
ELK3, ETS-domain protein (SRF accessory protein 2) |
12q23 |
1(0/1/0)
|
TAS[7958835]
|
| CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
15q13.3 |
4(2/2/0)
|
IDA[8906617]
|
| ARNTL |
aryl hydrocarbon receptor nuclear translocator-like |
11p15 |
7(5/2/0)
|
IEA
|
| PRKCZ |
protein kinase C, zeta |
1p36.33-p36.2 |
1(1/0/0)
|
TAS[8224878]
|
| HSP90AA1 |
heat shock protein 90kDa alpha (cytosolic), class A member 1 |
14q32.33 |
1(1/0/0)
|
NAS[11470816]
|
| NPAS3 |
neuronal PAS domain protein 3 |
14q13.1 |
2(1/1/0)
|
IEA
|
| NR4A2 |
nuclear receptor subfamily 4, group A, member 2 |
2q22-q23 |
1(0/1/0)
|
NAS[7877627]
|
| PER2 |
period circadian clock 2 |
2q37.3 |
7(1/6/0)
|
IEA
|
| GNRH1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
8p21-p11.2 |
1(0/1/0)
|
TAS[8692981]
|
| PER1 |
period circadian clock 1 |
17p13.1 |
5(2/3/0)
|
IEA
|
| ADCY8 |
adenylate cyclase 8 (brain) |
8q24 |
4(2/1/1)
|
TAS
|
| NCK2 |
NCK adaptor protein 2 |
2q12 |
1(1/0/0)
|
TAS[9737977]
|
| INPP1 |
inositol polyphosphate-1-phosphatase |
2q32 |
1(0/1/0)
|
TAS[8390685]
|
| GDNF |
glial cell derived neurotrophic factor |
5p13.1-p12 |
1(1/0/0)
|
TAS[7830769]
|
| CHL1 |
cell adhesion molecule L1-like |
3p26 |
1(1/0/0)
|
TAS[9799093]
|
| GRIN2D |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
19q13.33 |
1(1/0/0)
|
NAS[9480759]
|
| IMPA1 |
inositol(myo)-1(or 4)-monophosphatase 1 |
8q21.1-q21.3 |
1(0/1/0)
|
IMP[1377913]
|
| CHRNB1 |
cholinergic receptor, nicotinic, beta 1 (muscle) |
17p13.1 |
1(1/0/0)
|
IMP[8872460]
|
| CHRM3 |
cholinergic receptor, muscarinic 3 |
1q43 |
1(0/1/0)
|
TAS[10940357]
|
| PPFIA1 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 |
11q13.3 |
1(1/0/0)
|
TAS[7796809]
|
| GNAL |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
18p11.22-p11.21 |
2(0/2/0)
|
TAS[8243272]
|
| DPYSL2 |
dihydropyrimidinase-like 2 |
8p22-p21 |
2(1/0/1)
|
TAS[8973361]
|
| ANXA1 |
annexin A1 |
9q21.13 |
1(0/0/1)
|
TAS[16130169]
|
| PPP2R2D |
protein phosphatase 2, regulatory subunit B, delta |
10q26.3 |
1(0/0/1)
|
IEA
|
| PLCG1 |
phospholipase C, gamma 1 |
20q12-q13.1 |
1(0/1/0)
|
NAS[7681365]; TAS
|
| ARNTL2 |
aryl hydrocarbon receptor nuclear translocator-like 2 |
12p12.2-p11.2 |
3(1/2/0)
|
IEA
|
| ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2q33.3-q34 |
2(1/1/0)
|
IDA[10572067]
|
| NPHP4 |
nephronophthisis 4 |
1p36 |
1(1/0/0)
|
NAS[12244321]
|
| AKAP10 |
A kinase (PRKA) anchor protein 10 |
17p11.1 |
1(1/0/0)
|
TAS[9326583]
|
| PPP2R2C |
protein phosphatase 2, regulatory subunit B, gamma |
4p16.1 |
2(1/1/0)
|
IEA
|
| CSF2RB |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
22q12.3 |
2(1/1/0)
|
NAS[1702217]
|
| MAPK10 |
mitogen-activated protein kinase 10 |
4q22-q23 |
1(0/1/0)
|
TAS[8654373]
|
| CAP2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
6p22.3 |
1(0/1/0)
|
TAS[7962207]
|
| TENM2 |
teneurin transmembrane protein 2 |
5q35 |
1(0/0/1)
|
IEA
|
| KIF13B |
kinesin family member 13B |
8p21 |
1(0/1/0)
|
NAS[10859302]
|
| PLA2G1B |
phospholipase A2, group IB (pancreas) |
12q24.31 |
4(1/3/0)
|
TAS[9886417]
|
| CLOCK |
clock circadian regulator |
4q12 |
12(5/7/0)
|
IEA
|
| EDAR |
ectodysplasin A receptor |
2q13 |
1(0/1/0)
|
IEA
|
| ADM |
adrenomedullin |
11p15.4 |
1(1/0/0)
|
TAS[10822232]
|
| MAP2K6 |
mitogen-activated protein kinase kinase 6 |
17q |
1(0/1/0)
|
TAS[8621675]
|
| PTPRT |
protein tyrosine phosphatase, receptor type, T |
20q12-q13 |
2(0/1/1)
|
NAS[16973135]
|
| NPAS2 |
neuronal PAS domain protein 2 |
2q11.2 |
5(3/2/0)
|
IEA
|
| NTS |
neurotensin |
12q21.31 |
1(0/1/0)
|
NAS[8954810]
|
| ADRA1A |
adrenoceptor alpha 1A |
8p21.2 |
2(0/2/0)
|
TAS[8396931]
|
| PNOC |
prepronociceptin |
8p21 |
1(0/1/0)
|
TAS[9521323]
|
| ADCY2 |
adenylate cyclase 2 (brain) |
5p15.3 |
2(1/1/0)
|
TAS
|
| CREBBP |
CREB binding protein |
16p13.3 |
1(0/1/0)
|
NAS[15261140]
|
| CSNK2A1 |
casein kinase 2, alpha 1 polypeptide |
20p13 |
2(0/2/0)
|
TAS[2174700]
|
| BRE |
brain and reproductive organ-expressed (TNFRSF1A modulator) |
2p23 |
1(0/1/0)
|
TAS[9737713]
|
| CHRNA6 |
cholinergic receptor, nicotinic, alpha 6 (neuronal) |
8p22 |
1(0/1/0)
|
TAS[8906617]
|
| ESR1 |
estrogen receptor 1 |
6q24-q27 |
1(0/1/0)
|
TAS[10749889]
|
| GJA1 |
gap junction protein, alpha 1, 43kDa |
6q22.31 |
1(1/0/0)
|
IDA[1696265]
|
| CCK |
cholecystokinin |
3p22.1 |
2(0/1/1)
|
TAS[10320330]
|
| VAPA |
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa |
18p11.2 |
1(1/0/0)
|
IMP[12761501]
|
| AHRR |
aryl-hydrocarbon receptor repressor |
5p15.33 |
1(1/0/0)
|
IEA
|
| IL1B |
interleukin 1, beta |
2q14 |
1(1/0/0)
|
TAS[10786823]
|
| PER3 |
period circadian clock 3 |
1p36.23 |
7(3/4/0)
|
IEA
|
| CCL2 |
chemokine (C-C motif) ligand 2 |
17q11.2-q21.1 |
3(1/2/0)
|
NAS[10770925]
|
| ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
10q21 |
17(13/3/1)
|
IEA
|
| CARTPT |
CART prepropeptide |
5q13.2 |
1(0/1/0)
|
TAS[8647455]
|
| PRKAR1A |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
17q24.2 |
1(1/0/0)
|
TAS
|
| IL15RA |
interleukin 15 receptor, alpha |
10p15.1 |
1(1/0/0)
|
TAS[8530383]
|
| CREM |
cAMP responsive element modulator |
10p12.1-p11.1 |
1(0/1/0)
|
TAS[7916662]
|
| FGF12 |
fibroblast growth factor 12 |
3q28 |
1(0/1/0)
|
TAS[10049777]
|
| P2RX4 |
purinergic receptor P2X, ligand gated ion channel, 4 |
12q24.32 |
1(0/1/0)
|
IDA[9016352]
|
| EGFR |
epidermal growth factor receptor |
7p12 |
1(0/0/1)
|
IDA[10572067]; TAS
|
| CREB1 |
cAMP responsive element binding protein 1 |
2q34 |
2(1/1/0)
|
TAS
|
| CHRNA5 |
cholinergic receptor, nicotinic, alpha 5 (neuronal) |
15q24 |
3(2/1/0)
|
NAS[9009220]
|
| INTS6 |
integrator complex subunit 6 |
13q14.3 |
1(1/0/0)
|
TAS[10467397]
|
| KCNH7 |
potassium channel, voltage gated eag related subfamily H, member 7 |
2q24.3 |
3(2/0/1)
|
IEA
|
| LRP8 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
1p32.3 |
1(1/0/0)
|
TAS[10380922]
|
| ROR2 |
receptor tyrosine kinase-like orphan receptor 2 |
9q22 |
1(0/1/0)
|
TAS[1334494]
|
| ARNT2 |
aryl-hydrocarbon receptor nuclear translocator 2 |
15q25.1 |
1(0/1/0)
|
IEA
|
| VIPR2 |
vasoactive intestinal peptide receptor 2 |
7q36.3 |
1(1/0/0)
|
TAS[7811244]
|
| PPP2R2A |
protein phosphatase 2, regulatory subunit B, alpha |
8p21.2 |
1(0/1/0)
|
IEA
|
| ITK |
IL2-inducible T-cell kinase |
5q31-q32 |
1(1/0/0)
|
TAS[8364206]
|
| MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
1p36 |
1(0/0/1)
|
NAS[15539461]
|
| IL2RB |
interleukin 2 receptor, beta |
22q13 |
2(1/1/0)
|
TAS[2785715]
|
| CRHBP |
corticotropin releasing hormone binding protein |
5q13.3 |
1(0/1/0)
|
TAS[7477348]
|
| PPP1R1B |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
17q12 |
1(0/1/0)
|
TAS[10604473]
|
| TRAIP |
TRAF interacting protein |
3p21.31 |
1(0/0/1)
|
TAS[9104814]
|
| PLCXD3 |
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
5p13.1 |
1(1/0/0)
|
IEA
|
| CTNND2 |
catenin (cadherin-associated protein), delta 2 |
5p15.2 |
1(0/1/0)
|
TAS[9223106]
|
| GABRA5 |
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
15q12 |
6(6/0/0)
|
TAS[1321750]
|
| CHRM1 |
cholinergic receptor, muscarinic 1 |
11q12-q13 |
1(0/1/0)
|
TAS[3443095]
|
| GRIA1 |
glutamate receptor, ionotropic, AMPA 1 |
5q33 |
2(2/0/0)
|
TAS[1311100]
|
| CDC42BPB |
CDC42 binding protein kinase beta (DMPK-like) |
14q32.32 |
1(0/1/0)
|
TAS[9418861]
|
| TRH |
thyrotropin-releasing hormone |
3q13.3-q21 |
1(1/0/0)
|
TAS[2126343]
|
| PILRA |
paired immunoglobin-like type 2 receptor alpha |
7q22.1 |
1(0/0/1)
|
IDA[10903717]
|
| CHRNA1 |
cholinergic receptor, nicotinic, alpha 1 (muscle) |
2q31.1 |
2(0/1/1)
|
TAS[7619526]
|
| INPP4A |
inositol polyphosphate-4-phosphatase, type I, 107kDa |
2q11.2 |
1(0/0/1)
|
TAS[7608176]
|
| STK24 |
serine/threonine kinase 24 |
13q31.2-q32.3 |
2(1/1/0)
|
TAS[9353338]
|
| ZDHHC13 |
zinc finger, DHHC-type containing 13 |
11p15.1 |
1(0/0/1)
|
IMP[12761501]
|
| CHRNA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
20q13.33 |
1(1/0/0)
|
IDA[8906617]
|
| PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
1p36.1 |
1(0/1/0)
|
TAS
|
| KCNK10 |
potassium channel, two pore domain subfamily K, member 10 |
14q31 |
1(1/0/0)
|
NAS[10880510]
|
| IGF1 |
insulin-like growth factor 1 (somatomedin C) |
12q23.2 |
1(1/0/0)
|
TAS[10448861]
|
| SLC20A1 |
solute carrier family 20 (phosphate transporter), member 1 |
2q13 |
1(0/1/0)
|
IMP[12761501]
|
| CHRNB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
1q21.3 |
1(1/0/0)
|
IDA[8906617]
|
| CHRNA2 |
cholinergic receptor, nicotinic, alpha 2 (neuronal) |
8p21 |
3(0/3/0)
|
IDA[8906617]
|
| PPP2R5C |
protein phosphatase 2, regulatory subunit B', gamma |
14q32.31 |
1(0/1/0)
|
NAS[8703017]
|
| EDARADD |
EDAR-associated death domain |
1q42.3 |
1(1/0/0)
|
IEA
|
| GUCA1A |
guanylate cyclase activator 1A (retina) |
6p21.1 |
2(0/1/1)
|
NAS[7983048]
|
| ADRBK2 |
adrenergic, beta, receptor kinase 2 |
22q11 |
3(2/1/0)
|
IEA
|
| CSNK1D |
casein kinase 1, delta |
17q25 |
4(2/2/0)
|
TAS[8786104]
|
| IMPA2 |
inositol(myo)-1(or 4)-monophosphatase 2 |
18p11.2 |
4(2/2/0)
|
TAS[9322233]
|
| CHRM4 |
cholinergic receptor, muscarinic 4 |
11p12-p11.2 |
1(0/1/0)
|
TAS[9603968]
|
| GRN |
granulin |
17q21.32 |
2(2/0/0)
|
NAS[1542665]
|
| NRGN |
neurogranin (protein kinase C substrate, RC3) |
11q24 |
2(1/1/0)
|
TAS[10075657]
|
| CHRNB4 |
cholinergic receptor, nicotinic, beta 4 (neuronal) |
15q24 |
2(1/1/0)
|
IDA[8906617]
|
| CHRNA3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
15q24 |
3(1/2/0)
|
IDA[8906617]
|
| OR3A1 |
olfactory receptor, family 3, subfamily A, member 1 |
17p13.3 |
1(0/0/1)
|
NAS[8921386]
|
| ADCY9 |
adenylate cyclase 9 |
16p13.3 |
2(1/1/0)
|
TAS
|
| GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
3p21.31 |
1(0/1/0)
|
TAS[7961880]
|
| BCR |
breakpoint cluster region |
22q11 |
2(1/1/0)
|
TAS[1657398]
|
| PRKCE |
protein kinase C, epsilon |
2p21 |
1(0/1/0)
|
TAS
|
| CHRNB3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
8p11.21 |
3(1/2/0)
|
TAS[7690916]
|
| CRH |
corticotropin releasing hormone |
8q13 |
2(1/1/0)
|
TAS[7867564]
|
| PENK |
proenkephalin |
8q23-q24 |
1(0/1/0)
|
TAS[7057924]
|
| CSNK1E |
casein kinase 1, epsilon |
22q13.1 |
5(1/3/1)
|
TAS[7797465]
|
| ADRA2A |
adrenoceptor alpha 2A |
10q25.2 |
1(0/1/0)
|
TAS[10896916]
|
| CXCL12 |
chemokine (C-X-C motif) ligand 12 |
10q11.1 |
1(0/0/1)
|
TAS[10491003]
|
| NAMPT |
nicotinamide phosphoribosyltransferase |
7q22.3 |
1(1/0/0)
|
TAS[8289818]
|
| OPTN |
optineurin |
10p14 |
1(0/0/1)
|
TAS[9488477]
|
Basic Info
